Refind
The New York Times

Key takeaways from The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences. Open at source

218
Reader View
Made me smarter
Read later
Edit
Most highlighted
Dr. Doblin’s quest to win mainstream acceptance of psychedelics took a significant leap forward on Monday when the journal Nature Medicine published the results of his lab’s study on MDMA
There’s been a sea change in attitudes about what not long ago was considered fringe science,” said Michael Pollan, whose best-selling book on psychedelics, “How to Change Your Mind,” has helped destigmatize the drugs in the three years since it was published. “Given the mental health crisis in this country, there’s great curiosity and hope about psychedelics and a recognition that we need new therapeutic tools.”
Your notes & highlights

  Save highlights in Reader View or with our Chrome extension.

This your link? Claim it

Made for busy people.
About RefindDeep DivesTopicsHashtagsHelpLegal
CreatorsCuratorsDevelopersPublishersSponsorsEducation
© 2021 Refind Inc.
Apple App StoreGoogle Play StoreChrome Web Store